Among the challenges of living with HIV is a higher risk of fatty liver, a condition that can lead to chronic disease, a liver transplant or even death. Kristine Erlandson, MD, a University of Colorado Department of Medicine faculty member, has found that a medication used to treat diabetes and obesity – and touted on social media for weight loss – can be a powerful weapon against a type of fatty liver disease in people with HIV.
CU Anschutz
Academic Office One
12631 East 17th Avenue
8601
Aurora, CO 80045